Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Atlas of gynecologic cytopathology with histopathologic correlations / / Christopher J. VandenBussche [and three others] ; contributors, Lynette Denny, Dina R. Mody, Cornelia L. Trimble
| Atlas of gynecologic cytopathology with histopathologic correlations / / Christopher J. VandenBussche [and three others] ; contributors, Lynette Denny, Dina R. Mody, Cornelia L. Trimble |
| Autore | VandenBussche Christopher J. |
| Pubbl/distr/stampa | New York : , : Demos Medical, , 2016 |
| Descrizione fisica | 1 online resource (214 p.) |
| Disciplina | 618.107582 |
| Soggetto topico |
Generative organs, Female - Cancer
Generative organs, Female - Diseases - Diagnosis |
| ISBN | 1-61705-210-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Share Atlas of Gynecologic Cytopathology: With Histopathologic Correlations; Chapter 1: Colposcopy; Chapter 2: Normal; Chapter 3: Infectious Organisms; Chapter 4: Negative for Intraepithelial Lesion and Malignancy; Chapter 5: Low-Grade Squamous Intraepithelial Lesion; Chapter 6: High-Grade Squamous Intraepithelial Lesion; Chapter 7: Atypical Squamous Cells of Uncertain Significance; Chapter 8: Squamous Cell Carcinoma; Chapter 9: Atypical Glandular Cells; Chapter 10: Adenocarcinoma
Chapter 11: Metastatic and Unusual MalignanciesChapter 12: Cervical Cancer Screening and Follow-up of Limited and Abnormal Screen Results; Acceptable Cancer Risks and Basis for Recommendations; Cervical Cancer Screening Guidelines in the United States (2012); Management of Unsatisfactory Cytology Screening Result; Negative Cytology with Absent or Insufficient Endocervical or Transformation Zone Component; Atypical Squamous Cell of Undetermined Significance; Low-Grade Squamous Intraepithelial Lesion; Management for Cytologic Diagnosis of Atypical Squamous Cells, Cannot Rule Out HSIL Management of HSILAtypical Glandular Cells and Adenocarcinoma in Situ; References; Index |
| Record Nr. | UNINA-9910797582203321 |
VandenBussche Christopher J.
|
||
| New York : , : Demos Medical, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Atlas of gynecologic cytopathology with histopathologic correlations / / Christopher J. VandenBussche [and three others] ; contributors, Lynette Denny, Dina R. Mody, Cornelia L. Trimble
| Atlas of gynecologic cytopathology with histopathologic correlations / / Christopher J. VandenBussche [and three others] ; contributors, Lynette Denny, Dina R. Mody, Cornelia L. Trimble |
| Autore | VandenBussche Christopher J. |
| Pubbl/distr/stampa | New York : , : Demos Medical, , 2016 |
| Descrizione fisica | 1 online resource (214 p.) |
| Disciplina | 618.107582 |
| Soggetto topico |
Generative organs, Female - Cancer
Generative organs, Female - Diseases - Diagnosis |
| ISBN | 1-61705-210-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Share Atlas of Gynecologic Cytopathology: With Histopathologic Correlations; Chapter 1: Colposcopy; Chapter 2: Normal; Chapter 3: Infectious Organisms; Chapter 4: Negative for Intraepithelial Lesion and Malignancy; Chapter 5: Low-Grade Squamous Intraepithelial Lesion; Chapter 6: High-Grade Squamous Intraepithelial Lesion; Chapter 7: Atypical Squamous Cells of Uncertain Significance; Chapter 8: Squamous Cell Carcinoma; Chapter 9: Atypical Glandular Cells; Chapter 10: Adenocarcinoma
Chapter 11: Metastatic and Unusual MalignanciesChapter 12: Cervical Cancer Screening and Follow-up of Limited and Abnormal Screen Results; Acceptable Cancer Risks and Basis for Recommendations; Cervical Cancer Screening Guidelines in the United States (2012); Management of Unsatisfactory Cytology Screening Result; Negative Cytology with Absent or Insufficient Endocervical or Transformation Zone Component; Atypical Squamous Cell of Undetermined Significance; Low-Grade Squamous Intraepithelial Lesion; Management for Cytologic Diagnosis of Atypical Squamous Cells, Cannot Rule Out HSIL Management of HSILAtypical Glandular Cells and Adenocarcinoma in Situ; References; Index |
| Record Nr. | UNINA-9910824205103321 |
|
VandenBussche Christopher J.
|
||
| New York : , : Demos Medical, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Atlas of gynecologic cytopathology with histopathologic correlations / / Christopher J. VandenBussche [and three others] ; contributors, Lynette Denny, Dina R. Mody, Cornelia L. Trimble
| Atlas of gynecologic cytopathology with histopathologic correlations / / Christopher J. VandenBussche [and three others] ; contributors, Lynette Denny, Dina R. Mody, Cornelia L. Trimble |
| Pubbl/distr/stampa | New York : , : Demos Medical, , 2016 |
| Descrizione fisica | 1 online resource (214 p.) |
| Disciplina | 618.107582 |
| Soggetto topico |
Generative organs, Female - Cancer
Generative organs, Female - Diseases - Diagnosis |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-210-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Share Atlas of Gynecologic Cytopathology: With Histopathologic Correlations; Chapter 1: Colposcopy; Chapter 2: Normal; Chapter 3: Infectious Organisms; Chapter 4: Negative for Intraepithelial Lesion and Malignancy; Chapter 5: Low-Grade Squamous Intraepithelial Lesion; Chapter 6: High-Grade Squamous Intraepithelial Lesion; Chapter 7: Atypical Squamous Cells of Uncertain Significance; Chapter 8: Squamous Cell Carcinoma; Chapter 9: Atypical Glandular Cells; Chapter 10: Adenocarcinoma
Chapter 11: Metastatic and Unusual MalignanciesChapter 12: Cervical Cancer Screening and Follow-up of Limited and Abnormal Screen Results; Acceptable Cancer Risks and Basis for Recommendations; Cervical Cancer Screening Guidelines in the United States (2012); Management of Unsatisfactory Cytology Screening Result; Negative Cytology with Absent or Insufficient Endocervical or Transformation Zone Component; Atypical Squamous Cell of Undetermined Significance; Low-Grade Squamous Intraepithelial Lesion; Management for Cytologic Diagnosis of Atypical Squamous Cells, Cannot Rule Out HSIL Management of HSILAtypical Glandular Cells and Adenocarcinoma in Situ; References; Index |
| Record Nr. | UNINA-9910511469103321 |
| New York : , : Demos Medical, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Berek & Hacker's gynecologic oncology [[electronic resource] /] / Jonathan S. Berek, Neville F. Hacker
| Berek & Hacker's gynecologic oncology [[electronic resource] /] / Jonathan S. Berek, Neville F. Hacker |
| Autore | Berek Jonathan S |
| Edizione | [Seventh edition.] |
| Pubbl/distr/stampa | Philadelphia, : Wolters Kluwer, 2021 |
| Descrizione fisica | 1 online resource (1727 pages) : illustrations |
| Disciplina | 616.99465 |
| Altri autori (Persone) | HackerNeville F |
| Soggetto topico |
Generative organs, Female - Cancer
Genital Neoplasms, Female Genitalia, Female - physiopathology |
| ISBN | 1-9751-4265-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | section I. General principles -- section II. Disease sites -- section III. Medical and surgical topics -- section IV. Quality of life. |
| Altri titoli varianti | Berek and Hacker's gynecologic oncology |
| Record Nr. | UNINA-9910794006803321 |
|
Berek Jonathan S
|
||
| Philadelphia, : Wolters Kluwer, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical ovarian & other gynecologic cancer
| Clinical ovarian & other gynecologic cancer |
| Pubbl/distr/stampa | [New York], : Elsevier Inc., ©2012- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.99/465 |
| Soggetto topico |
Generative organs, Female - Cancer
Ovaries - Cancer Ovarian Neoplasms Genital Neoplasms, Female |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Soggetto non controllato | Oncology |
| ISSN | 2212-9561 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Clinical ovarian and other gynecologic cancer |
| Record Nr. | UNISA-996207549103316 |
| [New York], : Elsevier Inc., ©2012- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Clinical ovarian & other gynecologic cancer
| Clinical ovarian & other gynecologic cancer |
| Pubbl/distr/stampa | [New York], : Elsevier Inc., ©2012- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.99/465 |
| Soggetto topico |
Generative organs, Female - Cancer
Ovaries - Cancer Ovarian Neoplasms Genital Neoplasms, Female |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 2212-9561 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Clinical ovarian and other gynecologic cancer |
| Record Nr. | UNINA-9910141441003321 |
| [New York], : Elsevier Inc., ©2012- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical ovarian cancer and other gynecologic malignancies
| Clinical ovarian cancer and other gynecologic malignancies |
| Pubbl/distr/stampa | Dallas, TX, : CIG Media Group, ©2008-©2011 |
| Disciplina | 614 |
| Soggetto topico |
Ovaries - Cancer
Generative organs, Female - Cancer Ovarian Neoplasms Genital Neoplasms, Female |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Soggetto non controllato | Oncology |
| ISSN | 1941-4404 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Clinical ovarian cancer |
| Record Nr. | UNISA-996204253903316 |
| Dallas, TX, : CIG Media Group, ©2008-©2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Clinical ovarian cancer and other gynecologic malignancies
| Clinical ovarian cancer and other gynecologic malignancies |
| Pubbl/distr/stampa | Dallas, TX, : CIG Media Group, ©2008-©2011 |
| Disciplina | 614 |
| Soggetto topico |
Ovaries - Cancer
Generative organs, Female - Cancer Ovarian Neoplasms Genital Neoplasms, Female Ovaires - Cancer Organes génitaux femelles - Cancer |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Soggetto non controllato | Oncology |
| ISSN | 1941-4404 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Clinical ovarian cancer |
| Record Nr. | UNINA-9910144994103321 |
| Dallas, TX, : CIG Media Group, ©2008-©2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
European journal of gynaecological oncology
| European journal of gynaecological oncology |
| Pubbl/distr/stampa | Padua, Italy, : S.O.G. srl, 1980- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Generative organs, Female - Cancer
Genital Neoplasms, Female Oncologie Gynaecologie |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 2709-0086 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910892608103321 |
| Padua, Italy, : S.O.G. srl, 1980- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fundamentals in gynaecologic malignancy / / edited by Amal Chandra Kataki and Debabrata Barmon
| Fundamentals in gynaecologic malignancy / / edited by Amal Chandra Kataki and Debabrata Barmon |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (486 pages) |
| Disciplina | 306.47 |
| Soggetto topico |
Generative organs, Female - Cancer
Genital Neoplasms, Female |
| ISBN | 981-19-5860-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Contents -- Epidemiology of Gynaecological Cancers -- 1 Carcinoma Cervix -- 2 Carcinoma Ovary -- 3 Carcinoma Corpus Uteri -- 4 Carcinoma Vulva -- 5 Carcinoma Vagina -- 6 Gestational Trophoblastic Disease -- 7 Conclusion -- References -- Molecular Profiling of Gynaecological Cancer and Breast Cancer -- 1 Introduction -- 2 Molecular Profiling Techniques -- 2.1 Polymerase Chain Reaction (PCR) -- 2.2 Real-Time PCR -- 2.3 Droplet Digital PCR (ddPCR) -- 2.4 Next-Generation Sequencing (NGS) -- 2.5 NGS Workflow -- 2.5.1 PCR Amplification -- 2.5.2 Massive Parallel Sequencing -- 2.5.3 Sequencing Data Analysis -- 3 Criteria for Evidence-Based Classification of Molecular Biomarkers -- 4 Microsatellite Instability-High Tumours and DNA Mismatch Repair Molecular Biomarkers -- 5 Germline Mutations Molecular Biomarkers -- 6 Molecular Profile of Gynaecologic Cancers -- 6.1 Endometrial Cancers Molecular Profile -- 6.2 Ovarian Cancers Molecular Profile -- 6.3 Cervical Cancers Molecular Profile -- 6.4 Breast Cancer Molecular Profile -- 7 Oncology Basket Trials and Precision Medicine -- 8 Multiomics and Systems Medicine Approach in Gynaecological Cancer and Breast Cancer -- 8.1 MultiOmics Studies on Breast Cancer (BRCA) -- 8.2 MultiOmics Studies on Gynaecological Cancer -- 9 Challenges of Molecular Profiling of Cancer -- 9.1 Lack of Randomized, Controlled Clinical Trials -- 9.2 Unavailability to Suitable Molecular Target Drugs -- 9.3 Challenge of Tumour Heterogeneity -- 9.4 Molecular Profiling Platform Variations -- 9.5 Challenges of Quality Control Measures for Molecular Profiling -- 9.6 Appropriate Condition for Molecular Profiling of Cancer -- 10 Future Perspective -- References -- Tumour Biomarkers in Gynaecologic Oncology -- 1 Introduction -- 2 Tumour Markers in Gynaecological Cancers.
3 Tumour Biomarkers in Ovarian Malignancies -- 3.1 Epithelial Ovarian Cancers -- 3.1.1 Carbohydrate Antigen or Carcinoma Antigen (CA125) -- 3.1.2 CA125 as Screening Marker for Ovarian Cancers -- 3.1.3 CA125 as Marker for Disease Monitoring in Ovarian Cancers -- 3.1.4 CA125 as Prognostic Marker in Ovarian Cancers -- 3.1.5 Human Epididymis Protein 4 (HE4) -- 3.1.6 Evaluation of Women with Pelvic Masses -- 3.1.7 Risk of malignancy index (RMI) -- 3.1.8 Risk of Ovarian Malignancy Algorithm (ROMA) -- 3.1.9 OVA1 Test -- 3.1.10 Carcinoembryonic Antigen (CEA) -- 3.1.11 Cancer Antigen 19-9 (CA 19-9) -- 3.2 Markers of Non-epithelial Ovarian Cancers (Non-EOC) -- 3.2.1 Human Chorionic Gonadotropin (hCG) -- 3.2.2 Serum Alpha-Fetoprotein (sAFP) -- 3.2.3 Inhibin and Activin -- 3.2.4 Osteopontin (OPN) -- 3.2.5 Kallikreins (KLK) -- 3.2.6 Bikunin -- 3.2.7 Mesothelin -- 3.2.8 Vascular Endothelial Growth Factor (VEGF) -- 3.2.9 Human Prostasin (PSN) -- 3.2.10 Apolipoprotein A-I (apoA-I) -- 3.2.11 Transthyretin (TTR) -- 3.2.12 Transferrin -- 3.2.13 Creatine Kinase B (CKB) -- 3.2.14 Lysophosphatidic Acid (LPA) -- 4 Cervical Cancer -- 4.1 Squamous Cell Carcinoma Antigen (SCC-Ag) -- 4.2 CYFRA 21-1 -- 5 Endometrial Cancer -- 6 Vulval Cancer -- References -- Cancer: Infection and Vaccines -- 1 Introduction -- 2 Mechanism of Action -- 3 Oncogenic Viruses -- 3.1 Papillomaviruses -- 3.2 Polyomaviruses -- 3.3 Epstein-Barr Virus (Human Herpesvirus 4 or HHV4) -- 3.4 Kaposi Sarcoma Herpesvirus (KSHV or Human Herpesvirus 8 or HHV8) -- 3.5 Retroviruses -- 3.6 Hepatitis Viruses -- 4 Oncogenic Bacteria -- 4.1 Helicobacter pylori -- 5 Parasites Causing Cancer -- 5.1 Schistosoma haematobium -- 5.2 Opisthorchis viverrini and Clonorchis sinensis -- 6 The Microbiome and Carcinogenesis -- 7 Infection Control and Prevention in Cancer Patients. 7.1 Hygiene -- 7.2 Device Associated Infection -- 7.3 Environmental Hygiene -- 7.4 Education and Awareness of Health Care Personals -- 8 Cancer Vaccines -- 8.1 Hepatitis B Vaccines -- 8.2 Human Papillomavirus Vaccines (HPV Vaccines) -- 9 Therapeutic Vaccines -- 9.1 Bacillus Calmette Guerin (BCG) -- 9.2 Sipuleucel-T -- 9.3 Talimogene Laherparepvec (T-VEC) -- 10 Conclusion -- References -- Imaging in Gynaecological Malignancies -- 1 Ultrasound -- 2 Computed Tomography (CT) -- 3 Magnetic Resonance Imaging (MRI) -- 4 PET-CT -- 5 Cervical Cancer -- 6 Endometrial Cancer -- 7 Ovarian Cancer -- 8 Vaginal Cancer -- 9 Vulval Malignancies -- 10 Leiomyosarcoma -- 11 Gestational Trophoblastic Neoplasia (GTN) -- 12 Imaging Nodal Disease (N-Staging) -- 13 Imaging Metastatic Spread (M-Staging) -- 14 Image-Guided Biopsy -- 15 Conclusions -- References -- Principles and Practice of Surgery in Gynaecological Cancer -- 1 Introduction -- 2 History -- 3 Roles of a Surgical Oncologist -- 4 Diagnosis and Staging -- 5 Curative Surgery -- 5.1 Surgery for Primary Cancer -- 5.2 Surgery for Metastatic Disease -- 5.3 Palliative Surgery -- 5.4 Preventive or Prophylactic Surgery -- 6 Conclusion -- References -- Principles of Chemotherapy, Targeted Therapy, and Immunotherapy in Gynaecological Malignancies -- 1 Introduction -- 2 Basic Principles -- 3 Growth of Tumour Cell -- 4 Log Kill Hypothesis -- 5 Resistance to Chemotherapy -- 6 Dose Intensity -- 7 Single Versus Combination Therapy -- 8 Different Chemotherapy Types -- 9 Routes of Administration -- 10 Chemotherapeutic Drugs Used in the Treatment of Gynaecological Cancer -- 10.1 Alkylating Agents -- 10.2 Platinum -- 10.3 Anti-tumour Antibiotics and Anthracylines -- 10.4 Antimetabolites -- 10.5 Vinca Alkaloids -- 10.6 Topoisomerase Inhibitors -- 10.7 Taxanes. 11 Targeted Therapies -- 11.1 Mechanisms of Action -- 11.2 Interruption of Signal Transduction Pathways -- 11.3 Induction of Apoptosis -- 11.4 Stimulation of the Immune Response -- 11.5 PI3K/mTOR/Akt Pathway -- 11.6 Poly(ADP-Ribose) Pathway -- 11.7 Principles of Immunotherapy -- 11.7.1 Tumour Immunbiology and Immunotherapy -- 12 Clinical Practice in Gynaecologic Oncology -- 12.1 Suitability for Immunotherapy -- 12.2 Antibodies Used as Immunogens -- 12.3 Cancer-Testis Antigen Vaccines -- 12.4 Dendritic Cell-Based Vaccines -- 12.5 Vaccines Designed to Generate Antibody Responses -- 12.6 Adoptive Cellular Therapy -- 12.7 Whole Tumour Antigen Vaccines -- 12.8 Immune Checkpoint Inhibitors -- 12.9 Immune Checkpoint Blockade Therapy in Endometrial Cancer -- 12.10 Immune Checkpoint Blockade Therapy in Cervical Cancer -- References -- Principles and Practice of Radiation Oncology -- 1 Introduction -- 2 Timeline of Radiation Therapy (RT) -- 3 Effects of Radiation Interaction -- 3.1 Interaction of Photons with Matter -- 3.2 Interaction of Charged Particles with Matter -- 3.2.1 Bragg Curve -- 3.2.2 Bremsstrahlung -- 3.3 Interaction of Neutron with Matter -- 4 Biological Basis of Radiation Therapy -- 5 External Beam Therapy (EBRT) -- 5.1 EBRT Treatment Machines -- 5.2 Steps of Radiation Treatment Planning -- 5.2.1 Patient Selection -- 5.2.2 Patient Simulation -- 5.3 Treatment Techniques of Radiation Therapy -- 5.3.1 Conventional Technique -- Limitation of Conventional Planning -- 5.3.2 Three-Dimensional Conformal Radiation Therapy (3DCRT) -- 5.3.3 Intensity-Modulated Radiation Therapy (IMRT) -- 5.3.4 Arc Radiation Therapy -- 5.3.5 Stereotactic Techniques -- 6 Image-Guided Radiation Therapy (IGRT) -- 7 Advances 4D Radiation Therapy -- 7.1 Imaging -- 7.2 Radiation Therapy -- 7.3 Electron Beam Therapy. 7.4 Heavy Particle Therapy -- 8 Brachytherapy -- 8.1 Role Brachytherapy in Gynaecological Cancer -- 8.2 2D Image-Based Intracavity Brachytherapy -- 8.3 3D Image-Based Intracavity Brachytherapy -- 9 Radiation Dosimetry in Radiation Therapy -- 10 The Implication of Quality Assurance (QA) in RT -- 11 Radiation Protection -- 11.1 Classified Radiation Workers -- 11.2 Pregnant Radiation Worker -- 11.3 Apprentices and Trainee -- References -- Benign Breast Diseases -- 1 Introduction -- 2 Spectrum of Benign Breast Diseases -- 3 Approach to a Patient with Breast Disease -- 4 Investigations -- 4.1 Ultrasound (US) -- 4.2 Mammography -- 4.3 Magnetic Resonance Imaging (MRI) -- 4.4 Fine-Needle Aspiration Cytology (FNAC) -- 4.5 Core Needle Biopsy -- 4.6 Incision Biopsy -- 4.7 Excision Biopsy -- 5 Classification of Benign Breast Lesions -- 5.1 Breast Cysts -- 5.2 Galactocele -- 5.3 Usual Ductal Hyperplasia -- 5.4 Intraductal Papillomas -- 5.5 Diffuse Papillomatosis (Multiple Papillomas) -- 5.6 Juvenile Papillomatosis -- 5.7 Sclerosing Adenosis -- 5.8 Radial Scars (Complex Sclerosing Lesions) -- 5.9 Galactorrhoea -- 5.10 Periductal Mastitis and Ductal Ectasia -- 5.11 Infective Conditions of the Breast -- 5.12 Mastalgia -- 5.13 Mondor's Disease [49] -- 5.14 Traumatic Fat Necrosis [50] -- 5.15 Gynecomastia -- 6 Benign Proliferative Stromal Lesions -- 6.1 Diabetic Fibrous Mastopathy -- 6.2 Pseudoangiomatous Stromal Hyperplasia of the Breast -- 7 Benign Neoplasms -- 7.1 Fibroadenoma -- 7.2 Lipoma -- 7.3 Tubular Adenoma -- 7.4 Hamartoma -- 7.5 Granular Cell Tumour -- 7.6 Phyllodes Tumour -- 8 Conclusion -- References -- Breast Cancer -- 1 Incidence and Etiology -- 2 Risk Factors for Breast Cancer -- 2.1 Breast Pathology -- 2.2 Other Hormonal Factors -- 2.3 Reproductive Factors -- 2.4 History of Breast Cancer. 2.5 Lifestyle Factors. |
| Altri titoli varianti | Fundamentals in gynecologic malignancy |
| Record Nr. | UNINA-9910637722803321 |
| Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
